Exhaled nitric oxide (eNO) levels in asthmatic children: relation to atopy and airway responsiveness (AHR) Source: Eur Respir J 2004; 24: Suppl. 48, 271s Year: 2004
High levels of fractional exhaled nitric oxide (FeNO) in severe oral steroid-dependent asthma are associated with eosinophilia and atopy Source: Annual Congress 2009 - Airway inflammation and asthma control Year: 2009
Relationship between exhaled nitric oxide (eNO) and sputum eosinophils in severe asthma Source: Eur Respir J 2004; 24: Suppl. 48, 596s Year: 2004
Relationship between baseline fraction of exhaled nitric oxide (FeNO) and response to anti-IL-5/5R therapies in severe eosinophilic asthma (SEA) Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020
High levels of fractional exhaled nitric oxide (FeNO) only reflect the degree of allergen sensitization in mild childhood asthma Source: Annual Congress 2005 - Monitoring paediatric asthma Year: 2005
Serum IgE levels closely reflect blood eosinophilia and fractional exhaled nitric oxide levels but not pulmonary functions in children with mild allergic asthma Source: Eur Respir J 2003; 22: Suppl. 45, 399s Year: 2003
Exhaled nitric oxide (FeNO), sputum analysis and asthma control score in children with mild to moderate asthma Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008
Relationship between exhaled nitric oxide (eNO), atopy and asthma in children. ISAAC-clermont-ferrand Source: Eur Respir J 2001; 18: Suppl. 33, 38s Year: 2001
The relationship between exhaled nitric oxide and airway hyperresponsiveness in patients with asthma Source: Eur Respir J 2007; 30: Suppl. 51, 366s Year: 2007
Characterization of allergic airway inflammation in patients with COPD using fractional exhaled nitric oxide levels Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013
Increased alveolar nitric oxide concentration in asthmatic patients with nocturnal symptoms Source: Eur Respir J 2002; 20: 841-845 Year: 2002
Exhaled nitric oxide and lower airway involvement in persistent rhinitis Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers vs induced sputum Year: 2006
Correlation between exhaled nitric oxide, airway hyper responsiveness and pulmonary function data in patients with suspected asthma Source: Annual Congress 2009 - Airway inflammation and asthma control Year: 2009
Discordance between sputum eosinophil counts and exhaled nitric oxide levels in asthma Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers vs induced sputum Year: 2006
Comparisons for concentration in exhaled nitric oxide between patients with bronchial asthma and COPD Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007
Correlation of exhaled nitric oxide with IgE levels and eosinophils in blood in pediatric asthma Source: Eur Respir J 2002; 20: Suppl. 38, 142s Year: 2002
Benefit of inhaled corticosteroids (ICS) in asthmatic patients with bronchial hyperresponsiveness (BHR) to mannitol and low fractional exhaled nitric oxide (FeNO) levels Source: International Congress 2017 – Monitoring asthma control Year: 2017
Increased small airway involvement in asthma compared to those with rhinitis and bronchial hyperresponsiveness, measured by fractional nitric oxide (NO) and impulse oscillometry (IOS) Source: Eur Respir J 2005; 26: Suppl. 49, 735s Year: 2005
The relationship between exhaled breath nitric oxide, induced sputum and airway physiological responses in occupational asthma Source: Eur Respir J 2003; 22: Suppl. 45, 476s Year: 2003
Assessing inflammation non invasively: induced sputum, fractional exhaled nitric oxide concentration (FeNO), exhaled breath condensate (EBC) Source: Annual Congress 2006 - "Inflammometry": an alternative strategy in the management of airways disease Year: 2006